Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Choriomon® vs Marketed hCG in Healthy Women
NCT03735030Phase 1Completed
- Sponsor
- IBSA Group
- Start
- Nov 2018
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by IBSA Group. Primary endpoints: Rate of absorption (Cmax) and Extent of absorption (AUC0-t). Started Nov 2018; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03735030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735030.